ARTL - Artelo Biosciences Inc. Market Cap to Sales Volume

Corporate company logo of artelobio.com (ARTL)

Artelo Biosciences develops endocannabinoid system modulators to combat fibrosis and cancer-related anorexia. On GURU.Markets, the market capitalization-to-revenue ratio clearly visualizes the asset's dynamics, where this metric equals . However, strict government regulation and pressure from pharma behemoths create risks. The situation is further complicated by a lack of profit and a high cash burn rate on R&D processes.

ARTL Artelo Biosciences, Inc. Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Artelo Biosciences (ARTL) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart artelobio.com|ARTL - Consensus Target
- market capitalization statistics:
Market Value Artelo|ARTL - Enterprise Value
- book capitalization information:
Net Asset Value per Share Artelo Biosciences|ARTL - Company Book Value|Market Value to Book Value Ratio artelobio.com|ARTL - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Capital Artelo Biosciences|ARTL - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital artelobio.com|ARTL - Company Aggregate Debts|Debt to Book Capitalization Ratio Artelo|ARTL - Company Long-Term Debts|Short-Term Debt Volume Artelo Biosciences|Immediate Liquidity artelobio.com
- earnings and multiples data:
ARTL - Company Net Income|Company Profit Forecast Artelo Biosciences|ARTL - P/E Multiple|Projected Price to Earnings artelobio.com|ARTL - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Artelo|ARTL - Operating profit EBITDA|Net earnings per one share for the last twelve months Artelo Biosciences|ARTL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months artelobio.com|ARTL - Earnings growth in current year|Expected earnings per share growth for next year Artelo Biosciences
- total revenue and sales volume data:
ARTL - Revenue and Sales Volume|Company Expected Sales Volume artelobio.com|ARTL - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Artelo
General company analysis:Artelo Biosciences Inc. ARTL
Mass-produced product of Artelo Biosciences, Inc.

To assess the credit quality of Artelo Biosciences (ARTL), the analyst examines the price-to-sales ratio trend, which determines the market value of every dollar of revenue and helps identify the risk of overpaying for the asset. Stable utilization of contract manufacturing plants for cannabinoid production confirms operational resilience, which, combined with this indicator, helps the investor understand the extent to which current capitalization aligns with actual revenue generation rates.

Competing companies

INDV (indivior.com) - Market Capitalization-to-Revenue Ratio|Collegium Pharmaceutical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume CRON (Cronos Group Inc)|Tweed - P/S Multiple|Price to Sales Canna Cabana|auroramj.com (ACB) - Price-to-Revenue Ratio|ACHV (achievelifesciences.com) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Skye Bioscience|Price to Sales Anebulo Pharmaceuticals Inc ANEB|Market Cap to Revenue INCR (InterCure Ltd.)|NTRB (nutriband.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple NSRX (Nasus Pharma)|India Globalization Capital - Price-to-Revenue Ratio|MIRA Pharma - P/S Multiple|Price-to-Revenue Coefficient Flora Growth Corp FLGC|imcannabis.com (IMCC) - Price-to-Revenue Ratio|Price to Sales Adial Pharmaceuticals, Inc. (ADIL)|Price-to-Revenue Ratio Ensysce Biosciences Inc.|Titan Pharma (TTNP) - Price-to-Revenue Coefficient|P/S Multiple GNLN|Market Cap to Revenue InMed Pharmaceuticals Inc INM|P/S Multiple AKAN (Akanda Corporation)|Price-to-Revenue Coefficient Enveric Corp (ENVB)|Bright Green Corp - P/S Multiple|Price to Sales Hempacco Co Inc.